Discover management strategies for alopecia areata, from anti-inflammatory diets to stress reduction techniques that can help ...

Medically reviewed by Susan Bard, MD Alopecia areata is a common hair loss condition. It affects people of all ages, races, ...

Retail investor interest in Q32 Bio Inc picked up on Wednesday after the clinical-stage biotech said the U.S. Food and Drug ...

Experiencing hair fall is common, but excessive shedding signals underlying issues. Sudden hair loss, thinning, or bald spots ...

The Food and Drug Administration (FDA) has granted Fast Track designation to bempikibart for the treatment of alopecia areata (AA).

Bempikibart (ADX-914) is a human anti-IL-7Rα antibody that blocks the IL-7 and TSLP pathways, which have been implicated in driving T cell-mediated pathological processes in autoimmune diseases.

Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata (AA) and other autoimmune and inflammatory diseases, ...

Adding nbUVB phototherapy to oral ritlecitinib improves facial and total body repigmentation in patients with nonsegmental ...

The US Food and Drug Administration (FDA) has granted approval for AbbVie’s 15mg Rinvoq (upadacitinib) to treat adults with ...

My immune system attack left me with a bald patch and I have encountered many serums and oils - but this Philip Kingsley ...

Estelle Stoute's story of hair loss I started noticing hair everywhere—on my pillow, in the shower drain, clinging to my ...

Get ready to explore the world like never before! Priceline, the genAI-powered travel innovator, is introducing its Spring 2025 product release, Trip Intelligence: The Neighborhood Edition.